The Global Fecal Occult Blood Tests Market is expected to grow with a CAGR of 5.3% in the forecast period of 2023 to 2030. The years considered for the study are as mentioned below.
Access Full Report at @ https://www.databridgemarketresearch.com/ar/reports/global-fecal-occult-blood-tests-market
The global fecal occult blood tests market is a highly consolidated market, which includes equal number of key as well as local players. The market has witnessed increased strategic developments owing to a favorable market scenario.
Some of the major players dealing in the global fecal occult blood tests market are introducing a wide range of products along with adopting strategic initiatives such as acquisitions, agreements, business expansions, approvals and awards and recognitions into the market. This helps the companies maximize their sales with enhanced product portfolio.
For instance,
- In December 2021, Wondfo. announced that it had acquired Shenzhen Tisenc Medical Devices. With the acquisition, the companies aim is to expand its innovative layout in the field of CLIA diagnostics
- In January 2022, Boditech Med Inc. announced that it had signed a USD 19.2 Million supply agreement with A. Menarini Diagnostics to accelerate its product portfolio. This helps the organization in generating revenue
Quidel Corporation is the dominating player in the global fecal occult blood tests market. The other key players existing in the market include Wondfo, Siemens Healthcare GmbH, Eiken Chemical Co., Ltd., Biohit Oyj, EDP Biotech., CERTEST BIOTEC, Cenogenics Corporation, ulti med Products (Deutschland) GmbH, Alfa Scientific Designs, Inc., AccuBioTech Co., Ltd., Hangzhou Clongene Biotech Co., Ltd., CTK Biotech, Inc., HUMASIS.COM, Apacor Limited, Firstep, Epitope Diagnostics, Inc., Biopanda Reagents Ltd, Jant Pharmacal Corporation., Accuquik Test Kits., PRIMA Lab SA, Eurolyser Diagnostica GmbH, Boditech Med Inc., and Aidian, among others.
Quidel Corporation
Quidel Corporation was founded in the year 1979 and is headquartered in California, United States. The company focuses on a mission to provide diagnostic healthcare manufacturers serving to enhance the health and well-being of people around the globe by developing diagnostic solutions. The company has product categories such as Molecular Diagnostics, Immunoassays, DHI Cell Culture & Fluorescent tests in which market focused category is immunoassays.
The company has a wide presence across Asia-Pacific, North America, Europe, South America & Middle East and Africa. The company has various subsidiaries such as Pacific Biotech, Inc. (US), Metra Biosystems, Inc. (US), Osteo Sciences Corporation (US), Litmus Concepts, Inc. (US), and Diagnostic Hybrids, Inc. (US), among others.
Wondfo
Wondfo was founded in the year 1992 and is headquartered in Guangzhou, China. The company focuses on developing and manufacturing point-of-care testing (POCT) products and providing customers with professional rapid diagnosis and chronic disease management solutions. The company has product categories such as the Colloidal Gold Platform, Immunofluorescence Platform, Molecular Diagnostics Platform, Coagulation Platform and Chemiluminescence Platform in which market focused category is the Colloidal Gold Platform.
For Instance,
- In December 2021, Wondfo. announced that it had acquired Shenzhen Tisenc Medical Devices. With the acquisition, the companies aim is to expand its innovative layout in the field of CLIA diagnostics
The company has a wide presence across Asia-Pacific, North America, Europe, South America & Middle East and Africa. The company has various subsidiaries, such as Wondfo Biotech (HK) Co., Limited (Hong Kong), and Wondfo USA Co., Ltd. (U.S), among others.
Siemens Healthcare GmbH
Siemens Healthcare GmbH was founded in the year 1847 and is headquartered in Erlangen, Germany. The company focuses on breakthrough innovations to market to help healthcare professionals to deliver high-quality care, leading to the best possible outcome for patients. The company has product categories such as Medical Imaging, Varian-Cancer Care, Laboratory Diagnostics, Point-Of-Care Testing, Digital Health Solutions, Value Partnerships & Consulting Services, Accessories, OEM & Electronics, and Healthcare IT, in which market focused category is Laboratory Diagnostics.
The company has a wide presence across Asia-Pacific, North America, Europe, South America & Middle East and Africa. The company has various subsidiaries such as Siemens Healthcare Diagnostics Products GmbH, Marburg, Siemens Healthcare GmbH, Munich, Siemens Healthineers Beteiligungen GmbH & Co.KG, Rottenbach, Siemens Healthineers Beteiligungen Verwaltungs-GmbH, Rottenbach, and Siemens Healthineers Holding I GmbH, Munich, among others.
